نتایج جستجو برای: diffuse large b cell lymphoma

تعداد نتایج: 3216825  

Journal: :Blood 2013
Christian Gisselbrecht

In this issue of Blood, Matasar and colleagues report the results of salvage treatments with anti-CD20 ofatumumab in combination with ifosfamide, carboplatinum, etoposide (ICE) or dexamethasone, high-dose cytarabine, cisplatin (DHAP) in relapsed refractory diffuse large B-cell lymphoma (DLBCL) before transplantation. They conclude that replacing rituximab with ofatumumab in second-line therapy ...

2018
Filipa Duarte Ribeiro Henrique Coelho David Tente Margarida Badior

Cutaneous diffuse large B-cell lymphoma accounts for ~6% of all cutaneous lymphomas. It is associated with poor prognosis, and solitary lesions are relatively rare. It often requires an aggressive approach with multi-agent chemotherapy and radiotherapy. It is important to recognize these cases in order to offer rapid and appropriate management.

Journal: :Haematologica 2008
Pier Paolo Piccaluga Andrea Califano Ulf Klein Claudio Agostinelli Beatriz Bellosillo Eva Gimeno Sergi Serrano Francisco Solè Yonghui Zang Brunangelo Falini Pier Luigi Zinzani Stefano A Pileri

BACKGROUND Follicular lymphomas are currently subdivided into grades I, II, IIIa and IIIb. This distinction is, however, questioned. DESIGN AND METHODS We studied the gene expression profile of 43 follicular lymphomas, 50 B-cell non-Hodgkin's lymphomas of different histotype, and 20 samples of normal B-lymphocytes in order to assess: (i) the relationship of follicular lymphoma with normal B c...

2012
Catherine Thieblemont Marie-Hélène Delfau-Larue Bertrand Coiffier

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma (NHL) in adults. Even if the natural history of DLBCL has been improved with the advent of immunochemotherapy, the survival results obtained with current treatment options clearly indicate that new agents or novel approaches are needed. Lenalidomide (Revlimid, Celgene Corporation, Summit, NJ, USA), an analog...

Journal: :Turkish journal of internal medicine 2021

Diffuse Large B-Cell Lymphoma is characterized by the infiltration of small vessels lymphoid cells. These cells are not seen in systemic circulation. Depending on involvement location, it may present with different clinics such as central nervous system and skin involvement. Therefore, diagnosis delay. Diagnosis based pathology. Herein we a rare patient who initially presented cellulitis was ul...

Journal: :acta medica iranica 0
saeid abediankenari department of immunology, immonogenetic research center, faculty of medicine, mazandaran university of medical sciences, sari, iran. ghasem janbabaei mollae department of hematology and oncology, mazandaran university of medical sciences, sari, iran. maryam ghasemi department of pathology, faculty of medicine, mazandaran university of medical sciences, sari, iran. yousef yousefzadeh department of immunology, immonogenetic research center, faculty of medicine, mazandaran university of medical sciences, sari, iran. masoud bahrami department of orthopedic, faculty of medicine, babol university of medical sciences, babol, iran. kamran alimoghaddam department of hematology and oncology, transplantation center, shariati hospital, tehran university of medical sciences, tehran, iran.

dendritic cells (dcs) are professional antigen presenting cells that have a potential role in the initiating of immune responses. the cell vaccination is a new strategy in treatment of infectious diseases and cancers. in this study, we have generated monocyte-derived dendritic cells of lymphoma patient's peripheral blood mononuclear cells then; these cells were used as vaccine in lymphoma patie...

Journal: :middle east journal of digestive diseases 0
zhamak khorgami aamir abbas saeed shoar amir reza radmard kiarash shams esfandabad anushirvan hedayat

primary colorectal lymphoma (pcl) is a rare condition that accounts for a small percentage of all gastrointestinal (gi) malignancies. there are several reports in the literature regarding the most common features of pcl. however, primary lymphoma in the rectosigmoid junction has been rarely reported. our case was a 67-year-old male who presented with non-specific symptoms of bowel obstruction w...

Journal: :Haematologica 2014
Wyndham H Wilson Jacoline E C Bromberg Maryalice Stetler-Stevenson Seth M Steinberg Lourdes Martin-Martin Carmen Muñiz Juan Manuel Sancho Maria Dolores Caballero Marjan A Davidis Rik A Brooimans Blanca Sanchez-Gonzalez Antonio Salar Eva González-Barca Jose Maria Ribera Margaret Shovlin Armando Filie Kieron Dunleavy Thomas Mehrling Michele Spina Alberto Orfao

The benefit of intrathecal therapy and systemic rituximab on the outcome of diffuse large B-cell lymphoma at risk of central nervous system disease is controversial. Furthermore, the effect of intrathecal treatment and rituximab in diffuse large B-cell and Burkitt lymphoma with occult leptomeningeal disease detected by flow cytometry at diagnosis is unknown. Untreated diffuse large B-cell (n=24...

Introduction: Most B-cell malignancies are diagnosed based on morphologic and immunohistochemical criteria. Some cases, however, still present a challenge for the pathologist to discriminate between reactive hyperplasia and neoplastic disorders. Molecular techniques can be used as a helpful diagnostic tool in these cases. In this study, we assessed the value of polymerase chain reaction (PCR) t...

2017
Jia-Jia Li Jing-Jing Zhang Xiu Wang Zi-Min Sun

17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) is a water soluble, semisynthetic derivative of endotoxin that has anticancer effects. The aim of the present study was to determine whether 17-DMAG enhances the apoptosis of lymphoma cells in diffuse large B-cell lymphoma. Apoptosis was induced in SU-DHL-4 diffuse large B-cell lymphoma cells treated with 17-DMAG, as evaluated by MTT...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید